683 A novel mechanism of neuropilin-1 inhibition results in improved tumor growth inhibition in vivo

• Eric Zhu,
• Daniel Blom,
• Shalini Sethumadhavan,
• Chengfeng Merriman,
• Katherine Molloy,
• Alexandria Fink,
• Shan Lou,
• Andrew Rogantino,
• Ameya Apte,
• Mandana abbassi,
• Tiffany Liao,
• Hongyue Dai,
• Aaron Fulgham,
• Jonathan Hurov,
• Pearl Huang

Affiliations

Eric Zhu

Cygnal Therapeutics, Cambridge, MA, USA

Daniel Blom

Cygnal Therapeutics, Cambridge, MA, USA

Shalini Sethumadhavan

Cygnal Therapeutics, Cambridge, MA, USA

Chengfeng Merriman

Cygnal Therapeutics, Cambridge, MA, USA

Katherine Molloy

Cygnal Therapeutics, Cambridge, MA, USA

Alexandria Fink

Cygnal Therapeutics, Cambridge, MA, USA

Shan Lou

Cygnal Therapeutics, Cambridge, MA, USA

Andrew Rogantino

Cygnal Therapeutics, Cambridge, MA, USA

Ameya Apte

Cygnal Therapeutics, Cambridge, MA, USA

Mandana abbassi

Cygnal Therapeutics, Cambridge, MA, USA

Tiffany Liao

Cygnal Therapeutics, Cambridge, MA, USA

Hongyue Dai

Cygnal Therapeutics, Cambridge, MA, USA

Aaron Fulgham

Cygnal Therapeutics, Cambridge, MA, USA

Jonathan Hurov

Cygnal Therapeutics, Cambridge, MA, USA

Pearl Huang

Cygnal Therapeutics, Cambridge, MA, USA